ISG to Study Medical Device Digital Service Providers

Key Takeaways

• ISG will release Medical Device Digital Services reports in October 2026
• Study surveys over 100 providers across engineering, compliance, and AI enablement
• Reports help enterprises assess vendor capabilities for AI‑driven medical devices
• Focus on US and Europe markets highlights regional regulatory nuances
• Quadrant model categorizes services into engineering, compliance, and post‑market AI

Pulse Analysis

The medical device industry is undergoing a rapid shift from standalone hardware to connected, data‑rich solutions. As manufacturers embed artificial intelligence, cloud services, and Internet‑of‑Things sensors, they face new complexities in design, compliance, and post‑market monitoring. To bring clarity to this evolving ecosystem, Information Services Group (ISG) announced a new Provider Lens® research series titled Medical Device Digital Services, slated for release in October 2026. Drawing on surveys of more than 100 specialized service firms, the study will map the competitive landscape and give enterprise buyers a benchmark for selecting partners that can accelerate AI‑enabled product development.

ISG’s methodology divides the market into three quadrants: Digital Engineering and Product Development, Regulatory Compliance, Strategy and Quality Assurance, and AI‑driven Post‑Market Enablement. The first quadrant evaluates providers that deliver end‑to‑end digital design, simulation, and software integration, essential for creating connected devices that generate real‑time clinical insights. The compliance quadrant measures the ability to navigate FDA, EU MDR, and other global standards while aligning digital initiatives with go‑to‑market timelines. The post‑market quadrant focuses on AI platforms that monitor device performance, predict failures, and support continuous improvement, addressing both patient safety and lifecycle revenue.

For enterprise buyers, the Provider Lens reports become a decision‑support tool that reduces vendor risk and shortens time‑to‑market for AI‑enhanced devices. Service firms that demonstrate strong regulatory expertise and scalable AI delivery are likely to capture a larger share of the $150 billion global medical‑device software market, which is projected to grow at double‑digit rates through 2030. ISG’s global analyst network, spanning the United States and Europe, also ensures regional nuances are reflected, giving manufacturers a roadmap to build compliant, data‑driven products that meet both clinical and commercial objectives.